<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02930850</url>
  </required_header>
  <id_info>
    <org_study_id>TORR0002</org_study_id>
    <nct_id>NCT02930850</nct_id>
  </id_info>
  <brief_title>Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation</brief_title>
  <official_title>Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Masimo Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Masimo Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose study is to report on the accuracy of noninvasive hemoglobin (SpHb) as compared
      to hemoglobin measurements obtained from a laboratory hematology analyzer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this clinical investigation is to report on the accuracy of the
      Rad-67 and DCI Mini sensor to measure SpHb as compared to hemoglobin measurements obtained
      from a manual HiCN analytical method and automated Beckman Coulter laboratory hematology
      analyzers.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2016</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy of hemoglobin measurement</measure>
    <time_frame>Up to 2 hours per subject</time_frame>
    <description>Accuracy willl be determined by comparing the noninvasive hemoglobin measurement of the pulse oximeter to the hemoglobin value obtained from a blood sample and calculating the arithmetic root mean square(Arms) error value.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">447</enrollment>
  <condition>Anemia</condition>
  <condition>Healthy</condition>
  <condition>Pediatric ALL</condition>
  <arm_group>
    <arm_group_label>Test subjects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All subjects are enrolled and receive Rad-67 Pulse oximeter sensor for measurement of hemoglobin.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Rad-67 Pulse oximeter</intervention_name>
    <description>Noninvasive pulse oximeter that measures hemoglobin</description>
    <arm_group_label>Test subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age: Greater than one month

          -  Weight: Greater than or equal to 3kg

          -  The subject or the subject's legally authorized representative has given written
             informed consent/assent to participate in the study

        Exclusion Criteria:

          -  Subjects with skin abnormalities at the planned application sites that may interfere
             with sensor application, per directions-for-use (DFU) or trans-illumination of the
             site, such as burns, scar tissue, nail polish, acrylic nails, infections,
             abnormalities, etc.

          -  Subjects deemed not suitable for the study at the discretion of the investigator

          -  Subjects unlikely to be able to refrain from excessive motion during data collection.
             Excessive motion includes postural changes, making hand gestures, involuntary muscular
             movements, etc.

          -  Decision-impaired adult and pediatric subjects who are unable to give consent and
             assent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Site 4</name>
      <address>
        <city>Burbank</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site 5</name>
      <address>
        <city>Burbank</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site 2</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site 7</name>
      <address>
        <city>Lake Forest</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site 3</name>
      <address>
        <city>National City</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site 6</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site 1</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>October 10, 2016</study_first_submitted>
  <study_first_submitted_qc>October 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 12, 2016</study_first_posted>
  <disposition_first_submitted>April 1, 2019</disposition_first_submitted>
  <disposition_first_submitted_qc>April 1, 2019</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">April 8, 2019</disposition_first_posted>
  <last_update_submitted>April 1, 2019</last_update_submitted>
  <last_update_submitted_qc>April 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

